as an investor in biotech co's. and in gnbt I believe we are at the apex with gnbt. The conf. call today was a little on the unprofessioal side, but the bottomline is that there is interest in the company from the buyout/merger/distribution side as well as the venture capital/financial banking side. there is good news from India and the middle east in that they are finally selling product, creating a revenue stream. the pipeline is substantial and progressing. the flagship phase 111 trial is advancing as well as could be expected, finishing late 09-early 10 with fda approval to follow, numerous other drugs at various stages of development and testing. the company is in a quiet phase which I interpret to be good news ie; [merger/acqu./financing, etc.]...in short for a research and development biotech co. this rocket is on the launch pad and is being fueled,barring some unforseen blowup this co. will be selling for serious $$$$$$$ from where we are now.....IMHO
Guys, I just don't see big pharma in this. My gut tells me they will do either a JV (likely) or a VC (Most likely). The next press release will most likely be that they've 1) hired a PR to handle the CCs in the future (we can only hope) and 2) that they've hired a Investment Strategy group (say a GS/MS/ type) to assist in the process. The investment group will find an invester to give them cash. They will remove management and take over. We will do VERY well but I do not believe this is the team to take us to the next level. JUST how I see it. My best to everyone.